Virtus Fund Advisers, LLC Neurocrine Biosciences Inc Transaction History
Virtus Fund Advisers, LLC
- $26.8 Million
- Q4 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 795 shares of NBIX stock, worth $75,437. This represents 0.4% of its overall portfolio holdings.
Number of Shares
795
Previous 768
3.52%
Holding current value
$75,437
Previous $88,000
22.73%
% of portfolio
0.4%
Previous 0.44%
Shares
7 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
95.9MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.35 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$960 Million0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$464 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$286 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$241 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $9.08B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...